AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
Log in

OTCMKTS:CAPSCapstone Therapeutics Stock Price, Forecast & News

$18.00
+2.00 (+12.50 %)
(As of 05/26/2020 04:00 PM ET)
Add
Compare
Today's Range
$18.00
Now: $18.00
$18.00
50-Day Range
$16.00
MA: $16.16
$18.00
52-Week Range
$12.00
Now: $18.00
$26.00
Volume130 shs
Average Volume237 shs
Market Capitalization$972,000.00
P/E RatioN/A
Dividend YieldN/A
Beta239.63
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.80 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CAPS
CUSIPN/A
Phone602-286-5520

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2 million
Book Value($22.87) per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$972,000.00
Next Earnings Date6/1/2020 (Estimated)
OptionableNot Optionable

Receive CAPS News and Ratings via Email

Sign-up to receive the latest news and ratings for CAPS and its competitors with MarketBeat's FREE daily newsletter.

Capstone Therapeutics (OTCMKTS:CAPS) Frequently Asked Questions

How has Capstone Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

Capstone Therapeutics' stock was trading at $16.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CAPS shares have increased by 10.8% and is now trading at $18.00. View which stocks have been most impacted by Coronavirus.

When is Capstone Therapeutics' next earnings date?

Capstone Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, June 1st 2020. View our earnings forecast for Capstone Therapeutics.

How were Capstone Therapeutics' earnings last quarter?

Capstone Therapeutics Corp (OTCMKTS:CAPS) released its quarterly earnings data on Monday, August, 13th. The biotechnology company reported $0.02 earnings per share (EPS) for the quarter. The biotechnology company had revenue of $2 million for the quarter. View Capstone Therapeutics' earnings history.

Has Capstone Therapeutics been receiving favorable news coverage?

Press coverage about CAPS stock has trended negative this week, InfoTrie reports. The research firm rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Capstone Therapeutics earned a news sentiment score of -2.6 on InfoTrie's scale. They also gave news headlines about the biotechnology company a news buzz of 9.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near term. View the latest news aboutCapstone Therapeutics.

Who are some of Capstone Therapeutics' key competitors?

What other stocks do shareholders of Capstone Therapeutics own?

Who are Capstone Therapeutics' key executives?

Capstone Therapeutics' management team includes the following people:
  • Mr. John M. Holliman III, Exec. Chairman & Principal Exec. Officer (Age 65)
  • Mr. Leslie M. Taeger, Sr. VP, CFO and Principal Accounting & Financial Officer (Age 68)
  • Dr. Randolph C. Steer, Consultant (Age 69)
  • Dr. William M. Wardell M.D., Ph.D., Head of Clinical & Regulatory Review Board (Age 80)
  • Ms. Karen Struck, Investor Relations Professional

What is Capstone Therapeutics' stock symbol?

Capstone Therapeutics trades on the OTCMKTS under the ticker symbol "CAPS."

How do I buy shares of Capstone Therapeutics?

Shares of CAPS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Capstone Therapeutics' stock price today?

One share of CAPS stock can currently be purchased for approximately $18.00.

How big of a company is Capstone Therapeutics?

Capstone Therapeutics has a market capitalization of $972,000.00 and generates $2 million in revenue each year.

What is Capstone Therapeutics' official website?

The official website for Capstone Therapeutics is www.capstonethx.com.

How can I contact Capstone Therapeutics?

Capstone Therapeutics' mailing address is 1275 W. Washington Street Suite 104, Tempe AZ, 85281. The biotechnology company can be reached via phone at 602-286-5520 or via email at [email protected]

This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.